A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer - Related Studies

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

This study has been completed.

Study NCT00001570. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Kidney Neoplasms
		Neoplasm Metastasis

2	Additional conditions recognized in this trial
		Neoplasms

3	More general conditions related to this trial
		Kidney Diseases
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		PSC 833
		vinblastine

5	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		National Cancer Institute (NCI)